CADue in 1 day · Sep 18, 2026
Department of Social Services
The purpose of the SDNP is to ensure the effective resettlement of refugees and other eligible noncitizens through culturally and linguistically appropriate services and promote refugee advancement past self-sufficiency and towards long-term integration in San Diego County. Under the leadership of a single grantee, the SDNP will provide RCA and RSS to eligible RCA-type individuals and families who are not potentially eligible for CalWORKs.
Title 45 Code of Federal Regulations (CFR) Section (§) 400.69, authorizes the California Department of Social Services to establish an alternative approach to the administration of the RCA program rather than one modeled after the TANF program. Additionally, Welfare and Institutions Code (WIC) sections 13302-13307 authorize the California Department of Social Services (CDSS) to award funding to qualified nonprofit organizations to provide services to immigrants residing in, or formerly residing in, the State of California.
Amount not specifiedOfficial notice ↗ FederalDue in 1 day · Sep 18, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged.
Distinctive Features: The FY26 CTRA offers two funding levels:
• Funding Level 1 to support smaller, less complex preclinical and/or clinical research.
• Funding Level 2 to support larger, more complex preclinical and/or clinical research.
The FY26 CTRA also offers a Partnering PI Option (PPIO) to support meaningful and productive partnerships between two investigators collaborating on the proposed research project. The PPIO has two eligibility categories:
• Early-Career Partnering PI category for an independent, early-career investigator within 10 years of their first faculty appointment (or equivalent) by the time of application submission.
• Established Interdisciplinary Partnering PI for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy, seeking to transition to a career in DMD, thereby bringing their expertise to the field.
Preliminary data are required for all applications. Pilot clinical trials and clinical trial readiness studies to better inform development of drugs, devices, and other interventions are allowed.
Amount not specifiedOfficial notice ↗ FederalDue in 1 day · Sep 18, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD) in the near term. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. The DMDRP strongly encourages research projects investigating therapies designed to demonstrate efficacy cross the life span, including infants, toddlers and nonambulatory individuals.
Distinctive Features: The FY26 DMDRP IDA mechanism offers three eligibility career categories:
• The Established Investigator category is for independent investigators at all academic levels, or equivalent
• The New Investigator – Early-Stage category is for independent investigators early in their careers (i.e., within 10 years of their first faculty appointment or equivalent). Applicants in this category will be reviewed separately from Established Investigators.
• The New Investigator – Transitioning category is for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy who are seeking to transition to a career in DMD, thereby bringing their expertise to the field. Applicants in this category will be reviewed separately from Established Investigators.
Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required for all applications. Clinical trials or clinical trial aims are not allowed.
Amount not specifiedOfficial notice ↗ FederalDue in 1 day · Sep 18, 2026
National Institutes of Health
This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human subject research study results through accrual in a variety of community settings. The purpose of NCORP is to engage cancer patient populations, those at risk of cancer, and organizations in rigorous studies focused on cancer control, prevention, treatment and care delivery.NCORP is a community-based research network that:Designs and conducts clinical trials and other human subject studies for adults and children in cancer control, prevention, screening, and care delivery, as well as quality-of-life studies embedded within treatment trials;Enhances patient and provider access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN);NCORP will support the following components that will be individually awarded through the respective Request for Applications (RFAs) indicated below:NCORP Research Bases (UG1 Clinical Trials Required)(covered by this NOFO);NCORP Community Sites (UG1 Clinical Trials Not Allowed); andNCORP Academic Community Sites (UG1 Clinical Trials Not Allowed).NCORP Research Bases will serve as the program's research hubs and are expected to:Provide an established organizational structure, with scientific and statistical leadership for developing, implementing, and analyzing multi-institutional cancer control, prevention, and care delivery (CCP&CD) clinical research, as well as quality-of-life studies embedded in treatment and imaging studies.Assume responsibility for study operations and data management, including efficient protocol development; compliance with Food and Drug Administration (FDA) and Office of Human Research Protections (OHRP) regulatory and participant protection requirements; auditing; training; quality assurance; and support to Community Sites and Academic Community Sites.Be based at institutions with comprehensive cancer clinical research expertise (e.g., NCI-designated Cancer Center, or healthcare research organization – including NCI's National Clinical Trials Network (NCTN) Group Operations Centers, or a cancer foundation associated with a NCTN Group).
Amount not specifiedOfficial notice ↗ FederalDue in 1 day · Sep 18, 2026
National Institutes of Health
This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human subject research study results through accrual in a variety of community settings. The purpose of NCORP is to engage cancer patient populations, those at risk of cancer, and organizations in rigorous studies focused on cancer control, prevention, treatment and care delivery.NCORP is a community-based research network that:Designs and conducts clinical trials and other human subject studies for adults and children in cancer control, prevention, screening, and care delivery, as well as quality-of-life studies embedded within treatment trials;Enhances patient and provider access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN)NCORP will support the following components that will be individually awarded through the respective Request for Applications (RFAs) indicated below:NCORP Research Bases (UG1 Clinical Trials Required);NCORP Community Sites (UG1 Clinical Trials Not Allowed)(covered by this NOFO); andNCORP Academic Community Sites (UG1 Clinical Trials Not Allowed).The NCORP Community Sites is a healthcare system, a consortium of healthcare systems, or a consortia of community hospitals and/or oncology practices, public hospitals, and/or health care centers that can enhance the representativeness of participants accrued to cancer control, prevention, treatment and care delivery clinical trials and other human subjects research conducted through NCORP and NCTN.
Amount not specifiedOfficial notice ↗ FederalDue in 1 day · Sep 18, 2026
Library of Congress
This funding opportunity is authorized under the “Legislative Branch Appropriations Act of 2023” (Pub. L. 117-389 (H.R. 8237)), subject to availability of funding. The resulting awards will be subject to the Library of Congress Regulation (LCR) 7-310. In addition, while the Library, as a legislative agency, is not subject to 2 CFR 200 – Uniform Administrative Requirements, Costs Principles and Audit Requirements for Federal Awards, the resulting awards will be subject to selective provisions of 2 CFR 200 as determined by the Library and indicated in this NOFO.
About the Library of Congress
The Library of Congress is the largest library in the world, with millions of books, films and video, audio recordings, photographs, newspapers, maps and manuscripts in its collections. The Library is the main research arm of the U.S. Congress. It is the nation’s oldest federal cultural institution.
The Library’s mission is to engage, inspire, and inform Congress and the American people with a universal and enduring source of knowledge and creativity.
About the Teaching with Primary Sources Program (TPS)
The Teaching with Primary Sources program (www.loc.gov/teachers) has been the Library of Congress’s premier educational grant program since 2006. The goals of the program have included providing instructional materials, tools, education and professional development that enhance teachers’ ability to integrate digitized primary sources from the Library of Congress into instruction that builds student literacy, critical thinking skills, content knowledge and ability to conduct original research. Since the establishment of the Center for Learning, Literacy and Engagement in 2018, and the release of the Library’s 2024-2028 Strategic Plan, the TPS goals both influence and reflect the Library’s broader outreach goals.
About the Lewis-Houghton Civics and Democracy Initiative (LHI)
Named in honor of Rep. John R. Lewis (D-GA) and Rep. Amo Houghton (R-NY), the Lewis-Houghton Civics and Democracy Initiative (LHI) is included under the Teaching with Primary Sources (TPS) program. In the joint explanatory statement for the Legislative Branch Appropriations Act, 2023, Congress established the Lewis-Houghton Civics and Democracy Initiative and appropriated funds to the Library of Congress to award grants to eligible organizations within the United States (U.S.) and its territories to develop digitally-enabled, creative arts-driven projects focused on using the digitized primary sources of the Library of Congress to teach history, civics and/or democracy. More information and a description of past LHI-funded projects can be found at: https://www.loc.gov/programs/teachers/about-this-program/teaching-with-primary-sources-partner-program/lewis-houghton/.
TPS Educational Consortium
Grantee organizations become members of the TPS Educational Consortium. They include a wide variety of educational organizations including school districts, libraries, cultural institutions, universities and technology firms that have received Library funding to deliver teacher professional development, create teaching materials and develop apps and online interactives, based on Library of Congress materials.
TPS Consortium members are valued as “Connectors” who help the Library achieve its vision of connecting to all Americans. TPS Consortium members extend the Library’s reach by connecting hundreds of thousands of American educators and learners, including K-12 teachers and their students, to Library of Congress methods and materials. Consortium members collaborate, co-create, share ideas, network and actively participate as an educational community.
Purpose
The purpose of this notice is for the Library of Congress to solicit project proposals from eligible organizations and select awardee organizations that will design and implement educational projects in which the Library’s music or creative arts-related digitized primary sources and other online materials are central to teaching and learning about history, civics, and/or democracy.
Awards made under Lewis-Houghton Civics and Democracy Initiative must include rights-free materials from the Library’s music or creative arts digital collections, to develop curriculum, teaching materials, educational programs, pedagogical approaches, and/or other tools for history, civic and democracy instruction targeted toward middle and high school educators and learners. LHI awards should center on inquiry-driven analysis of primary sources, build learners’ civic skills and foster participation in our nation’s democracy.
In addition to highlighting primary sources from the Library’s collections of music, dance, theater, visual arts, folk arts, film, photography, book arts, arts and literary manuscripts, and/or other creative arts, proposals may also include the use of arts-based pedagogies and other creative approaches. All proposals must expand the body of innovative strategies, tools, and materials for meanin…
FederalDue in 1 day · Sep 18, 2026
Assistant Secretary for Preparedness and Response
A trauma system is, “…an organized, inclusive approach to facilitating and coordinating a multidisciplinary system response to severely injured patients.”[14] Coordination across prehospital entities (e.g., EMS) and hospitals signal an effective trauma system, where patients can get the right level of care they need. Access to trauma care in the United States is inconsistent. For example, 1 in 3 Americans live in a region with incomplete trauma care,[15] and 30 million Americans live over 60 minutes from a trauma care center.[16]
The Trauma Care Readiness and Coordination Program supports ASPR’s goal of strengthening state and local preparedness by funding and supporting efforts to improve coordination across EMS, pre-hospital providers, and hospitals.[17] Through this program, ASPR will help recipients test scalable models that improve trauma system readiness and patient access to the right level of care, ultimately improving health outcomes and saving lives.
$300,000 – $500,000Official notice ↗ FederalDue in 3 days · Sep 20, 2026
Geological Survey
The USGS is offering a funding opportunity to a CESU partner for research on brown treesnakes (Boiga irregularis) in the Pacific Islands. Brown treesnakes (BTS) have caused the severe decline, extirpation, or extinction of several native terrestrial vertebrate species in Guam. The USGS Pacific Island Ecosystems Research Center (PIERC) has staff on Guam and elsewhere that conduct research on biology and control of BTS to mitigate economic and ecological impacts and risks of BTS, including enhancing military readiness through participating in biosecurity and biosurveillance initiatives. USGS- PIERC also manages the BTS Rapid Response Team, which trains cooperators throughout the Pacific region and stands ready to respond to snake sightings on short notice. Research by USGS-PIERC on control and interdiction of brown treesnakes is currently funded by U.S. Department of the Navy, DOI Office of Insular Affairs, and the USGS Invasive Species Program.USGS is looking to leverage collaborations to incorporate skills in the capture, removal, detection, and technical familiarity with Guam into the broader research goals of long-standing USGS research on BTS in Guam.
CADue in 4 days · Sep 21, 2026
Department of Health Care Services
Through this round of Elevate Youth California (EYC) funding, the Department of Health Care Services (DHCS) is making approximately $44 million available to community-based, Tribal, and county behavioral health organizations throughout California to expand youth and young adult substance use prevention through policy, systems, and environmental change.
EYC is a statewide program that addresses substance use disorders (SUDs) by investing in leadership development and civic engagement for youth of color and 2S/LGBTQIA+ youth ages 12 to 26 living in communities disproportionately impacted by the war on drugs. This statewide program provides funding and technical assistance for organizations proposing to implement programs that empower youth to be community leaders and create positive policy and systems change. EYC funded partners will be responsible for implementing comprehensive strategies that reduce risk factors (e.g., trauma, disconnection from school/community) and enhance protective factors (e.g., cultural identity, adult/peer mentorship, community and civic engagement) associated with youth substance use prevention. Projects are recommended to utilize evidence-based, promising, and/or community-driven practices in their prevention approach and incorporate social justice youth development in all programming. Funded partners will conduct annual listening sessions to gather feedback from youth and young adults on the impact of prevention efforts and to identify opportunities for project improvement. Additionally, funded partners are expected to actively participate in technical assistance opportunities hosted by The Center, engage in an external evaluation to assess the effectiveness of EYC, and attend one-day regional convenings, at least two over the award period. EYC funded partners will be required to submit biannual progress and financial reports. Success will be measured by progress towards programmatic and policy, systems, and environmental change goals and objectives contained in an approved work plan, which must include processes for monitoring and evaluation of youth engagement, prevention activities, policy, systems, and environmental change, and participant outcomes through quantitative and qualitative methods. Additional indicators of success include participants' increased knowledge of SUD and its prevention, reduced stigma around substance use services, and evidence of community-level policy, systems, and environmental changes related to substance use issues or their root causes. Since the program’s launch, DHCS has awarded $370 million through 517 grant awards. For information about EYC, visit www.elevateyouthca.org.
FederalDue in 4 days · Sep 21, 2026
Bureau of International Labor Affairs
Questions regarding this Funding Opportunity Announcement (FOA) may be emailed to OGM_ILAB@dol.gov.
$8,000,000 – $18,000,000Official notice ↗ FederalDue in 4 days · Sep 21, 2026
Bureau of International Labor Affairs
Questions regarding this Funding Opportunity Announcement (FOA) may be emailed to OGM_ILAB@dol.gov.
$7,000,000 – $18,000,000Official notice ↗ FederalDue in 4 days · Sep 21, 2026
Bureau of International Labor Affairs
Questions regarding this Funding Opportunity Announcement (FOA) may be emailed to OGM_ILAB@dol.gov.
FederalDue in 4 days · Sep 21, 2026
Bureau of International Labor Affairs
Questions regarding this Funding Opportunity Announcement (FOA) may be emailed to OGM_ILAB@dol.gov.
FederalDue in 5 days · Sep 22, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have significant impact on the treatment and management of a disease or condition addressed in one of the congressionally directed FY26 PRMRP topic areas and FY26 PRMRP strategic goals.
Distinctive Features: Must support a clinical trial. Supports two different application categories, based on the phase of planning for the clinical trial: Clinical Trial Only or Clinical Trial with Planning Phase. The Clinical Trial with Planning Phase option is intended to support the final phase of regulatory activities and planning activities that are necessary to be completed prior to initiation of the clinical trial. The planning phase cannot be used to finalize the intervention or support animal studies. Applications that already have regulatory approvals in place and are submitting to the Clinical Trial Only option may be prioritized over those requesting the Planning Phase option. Animal studies are not supported. Studies must complete all preclinical empirical laboratory work prior to the award start date.
Supports three funding levels, each offered with and without a Planning Phase:
Funding Level 1: Supports phase 0 or phase 1 clinical trials or non-phased trials with fewer than 100 participants.
Funding Level 2: Supports phase 2 clinical trials or non-phased trials with fewer than 300 participants.
Funding Level 3: Supports phase 3 clinical trials or non-phased trials with more than 300 participants.
Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $94.5M to fund approximately 9 Clinical Trial Award applications with total cost caps of $800,000 for the planning phase of a Clinical Trial with Planning Phase, $6M for Funding Level 1, $10M for Funding Level 2, and $20M for Funding Level 3 per award. The maximum period of performance is 4 years for the clinical trial, and 12 months for the planning phase. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.
Amount not specifiedOfficial notice ↗ FederalDue in 5 days · Sep 22, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Platform Clinical Translation Award supports the translational development and/or early-phase clinical trials for broadly applicable clinical technologies that will address urgent and complex needs related to two congressionally directed FY26 PRMRP topic areas. The platform product in development should address one of the FY26 PRMRP portfolio-specific strategic goals and address the health care needs of military Service Members, Veterans and their Families.
Distinctive Features:
Allows for multiple Principal Investigators (PIs). The proposed experiments may represent a single project led by a single PI, or it may consist of partnerships between principal investigators that will occur synergistically to advance a platform product. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. Up to two additional PIs can be identified as Partnering PIs. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).
Requires a PI-convened external advisory board with patient advocate participation. The patient advocate must be a person living with, or a family member or caretaker of someone with, a disease or condition addressed in one of the applicant-selected congressionally directed FY26 PRMRP topic areas.
Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $30M to fund approximately two Platform Clinical Translation Award applications with total cost caps of $15M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with a maximum of $8M in FY26, with the remaining budget to be funded out of future fiscal years depending upon meeting performance-based milestones and availability of future funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.
Amount not specifiedOfficial notice ↗ FederalDue in 5 days · Sep 22, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Synergistic Idea Award (SIA) supports new ideas that represent synergistic approaches to neurofibromatosis (NF) research involving two or three Principal Investigators (PIs). These investigators should utilize their complementary and synergistic perspectives to address a central problem or question in NF research. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.
Distinctive Features:
• Partnering Principal Investigators: One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. An additional one or two PI(s) will be identified as a Partnering PI. Each partner will be recognized as a PI, submit a separate application (even if the partners are at the same organization), and receive an individual award.
Amount not specifiedOfficial notice ↗ FederalDue in 5 days · Sep 22, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Investigator-Initiated Research Award (IIRA) supports high-impact research that addresses a critical need and has the potential to make important contributions to the field of neurofibromatosis disorders or advance patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.
Distinctive Features: This award mechanism offers two funding levels based on participation in two optional features:
• Open Science Initiative: Catalyzes research for neurofibromatosis through early access to data and data sharing within the neurofibromatosis community.
• Optional Qualified Collaborator: Encourages collaborative research between basic scientists and clinical researchers, and between academic and biotechnology scientists.
The funding levels are defined as follows:
• Level 1: Applications without an optional feature.
• Level 2: Applications including one of the optional features.
Amount not specifiedOfficial notice ↗ FederalDue in 5 days · Sep 22, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported by this award mechanism should lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.
Distinctive Features:
• Innovation: The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities.
• Preliminary Data: Preliminary and/or published data is encouraged but not required.
Amount not specifiedOfficial notice ↗ CADue in 6 days · Sep 23, 2026
Department of Health Care Access and Information
The Song-Brown program funds institutions that train primary care health professionals to provide healthcare in California’s medically underserved areas.
This grant opportunity will result in funding organizations to train certified nurse midwifery students to work in underserved communities. Such strategies shall incorporate the following elements: 1. Establishing procedures to identify, recruit, and admit certified nurse midwifery students who possess characteristics which would suggest a predisposition to practice in areas of unmet need, and who express a commitment to serve in areas of unmet need. 2. Implementing counseling and placement programs to encourage training program graduates to enter practice in areas of unmet need. 3. Providing a preceptorship experience in an area of unmet need to enhance the potential of training program graduates to practice in such an area.
Amount not specifiedOfficial notice ↗ CADue in 6 days · Sep 23, 2026
Department of Health Care Access and Information
The Song-Brown program funds institutions that train primary care health professionals to provide healthcare in California’s medically underserved areas.
This grant opportunity will result in funding organizations to train primary carenurse practitioners and physician assistant trainees to work in underservedcommunities. Such strategies shall incorporate the following elements: 1. Establishing procedures to identify, recruit and admit primary care nursepractitioner and physician assistant trainees who possess characteristicswhich would suggest a predisposition to practice in areas of unmet need, andwho express a commitment to serve in areas of unmet need. 2. Implementing counseling and placement program to encourage trainingprogram graduates to enter practice in areas of unmet need. 3. Providing a preceptorship experience in an area of unmet need to enhancethe potential of training program graduates to practice in such an area.
Amount not specifiedOfficial notice ↗ FederalDue in 7 days · Sep 24, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Care Award (TrCA) supports clinical research or clinical trials evaluating interventions, innovations, and solutions in critical areas for dementia care for individuals with Alzheimer’s disease and Alzheimer’s disease related dementia (AD/ADRD) and their care partner(s).
Distinctive Features:
Clinical research and clinical trials are allowed; however, clinical trials solely testing or evaluating pharmacological interventions do not meet the intent of this funding opportunity.
Studies utilizing animal models do not meet the intent of the mechanism and are not allowed.
Preliminary data are required.
Community collaboration is required for research prospectively enrolling human subjects.
The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged.
Career Initiation or Transition (CIT) Partnership Option: The TrCA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet the CIT Partnership Option eligibility requirements at the time of application submission.
Amount not specifiedOfficial notice ↗ FederalDue in 7 days · Sep 24, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA) supports non-incremental, solutions-oriented research that reduces or overcomes important barriers to obtaining a diagnosis, meaningful disease monitoring and accurate prognosis.
Distinctive Features:
Clinical research is allowed, however clinical trials and animal research are prohibited.
Preliminary data are required.
Community collaboration is required for studies prospectively enrolling human subjects.
Study Population: The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged.
Career Initiation or Transition (CIT) Partnership Option: The TrDA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet the CIT Partnership Option eligibility requirements at the time of application submission.
Amount not specifiedOfficial notice ↗ FederalDue in 7 days · Sep 24, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, well-designed research that drives transformative advancements in reducing risk and preventing the development of Alzheimer’s disease and/or Alzheimer's disease related dementias (AD/ADRD).
Distinctive Features:
• Applications must address at least one of the following focus areas:
○ Risk Factor Knowledge: Research that advances understanding, identification, and/or validation of risk and/or protective factors, with research outcomes/products focused on accelerating solutions. Projects may include, but are not limited to, research on environmental, epigenetic, genetic, lifestyle, occupational, or other risks not listed here.
○ Risk Reduction Solutions: Research that describes methods, technologies, and strategies that contribute to reducing risk and preventing AD/ADRD.
• Clinical research is allowed, however clinical trials and animal research are prohibited.
• Preliminary data are required.
• Community collaboration is required for research prospectively enrolling human subjects.
• Career Initiation or Transition (CIT) Partnership Option: The TrRA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet
Amount not specifiedOfficial notice ↗ FederalDue in 7 days · Sep 24, 2026
National Institutes of Health
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.
Amount not specifiedOfficial notice ↗